To further investigated whether AGK-deficient macrophages enhanced CD8+ T cell anti-tumor functions through type I IFN signaling, we blocked type I IFN signaling in vivo with anti-IFNAR antibody in the LLC tumor model. This evidence concerns the gene CD8A and neoplasm.